Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nutra Pharma Corp NPHC

Healthcare Biotechnology
Nutra Pharma Corp. is a holding company, which owns intellectual property and operates in the biotechnology industry. The Company conducts drug discovery research and development activities on its own and through its subsidiary, ReceptoPharm, Inc. Its first consumer product, Cobroxin, is an over-the-counter pain reliever designed to treat moderate to severe chronic pain. Its second consumer... see more

Recent & Breaking News (GREY:NPHC)

Nutra Pharma's Rik Deitsch Interviewed by The Life Sciences Report

Marketwired October 22, 2015

Nutra Pharma to Present at Upcoming Investment Conference

Marketwired September 9, 2015

Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration for the Treatment of Juvenile Multiple Sclerosis

Marketwired September 8, 2015

Nutra Pharma Announces the Submission of Their First Orphan Drug Application to the US Food and Drug Administration (FDA)

Marketwired July 15, 2015

SeeThruEquity Initiates Coverage on Nutra Pharma Corporation with a Price Target of $0.53

Accesswire July 10, 2015

SeeThruEquity Initiates Coverage on Nutra Pharma Corporation with a Price Target of $0.53

Accesswire July 10, 2015

Nutra Pharma Announces Engagement of Investment Banking Firm Pickwick Capital Partners to Provide Strategic Advisory Services

Marketwired June 30, 2015

Nutra Pharma Announces Expansion and Upgrades for Nyloxin(R) Production

Marketwired June 23, 2015

UPDATE - Nutra Pharma Announces Collaboration with Nationwide Laboratories

Marketwired June 9, 2015

Nutra Pharma Announces Nyloxin(R) Distribution Plans for Canada

Marketwired May 14, 2015

Nutra Pharma Announces Nyloxin(R) Acceptance by Chinese Medical Authority - CPAM

Marketwired April 30, 2015

Nutra Pharma Announces Nyloxin(R) Distribution Plans for China

Marketwired April 22, 2015

Nutra Pharma Provides Updates on Marketing and Distribution of Nyloxin(R) to India

Marketwired April 15, 2015

Chairman & CEO Rik J. Deitsch of Nutra Pharma Corporation to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios - 640 WGST AM's "Health Tech Talk Live"

Marketwired February 20, 2015

Nutra Pharma Announces Distribution of Nyloxin(R) to India

Marketwired February 5, 2015

Nutra Pharma Announces Addition of Keith Gordon, DVM to the Company's Medical Advisory Board

Marketwired January 20, 2015

Nutra Pharma Announces Manufacturing Release of Pet Pain-Away and Delivery of Initial Orders

Marketwired December 17, 2014

Nutra Pharma Letter to Shareholders

Marketwired December 4, 2014

Nutra Pharma Announces Laboratory Recertification and Manufacturing Updates

Marketwired November 12, 2014

Nutra Pharma Retains BUYINS.NET to Surveil Short Sellers and Market-Makers

Marketwired August 21, 2014